Earnings estimate | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 6 | 3 | 14 | 14 |
Avg. Estimate | 0.46 | 0.31 | 1.49 | 1.63 |
Low estimate | 0.44 | 0.29 | 1.28 | 1.42 |
High estimate | 0.5 | 0.33 | 1.63 | 1.84 |
Year ago EPS | 0.49 | 0.34 | 1.52 | 1.49 |
Revenue estimate | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 6 | 3 | 13 | 13 |
Avg. Estimate | 8.49B | 8.76B | 33B | 33.55B |
Low estimate | 8.19B | 8.28B | 31.9B | 32.59B |
High estimate | 8.94B | 9.55B | 35.85B | 34.71B |
Year ago sales | 10.56B | 11.09B | 39.7B | 33B |
Sales growth (year/est) | -19.60% | -21.00% | -16.90% | 1.70% |
Earnings history | 30/09/2021 | 31/12/2021 | 31/03/2022 | 30/06/2022 |
---|---|---|---|---|
Est. EPS | 0.38 | 0.33 | 0.41 | 0.34 |
Actual EPS | 0.49 | 0.34 | 0.44 | 0.4 |
Difference | 0.11 | 0.01 | 0.03 | 0.06 |
Surprise % | 28.90% | 3.00% | 7.30% | 17.60% |
EPS trend | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Current estimate | 0.46 | 0.31 | 1.49 | 1.63 |
7 days ago | 0.44 | 0.29 | 1.44 | 1.57 |
30 days ago | 0.43 | 0.27 | 1.39 | 1.51 |
60 days ago | 0.46 | 0.29 | 1.48 | 1.6 |
90 days ago | 0.54 | 0.33 | 1.5 | 1.64 |
EPS revisions | Current qtr. (Sep 2022) | Next qtr. (Dec 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | 1 |
Up last 30 days | 1 | 1 | 5 | 6 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | 1 | N/A |
Growth estimates | GSK.L | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | -6.10% | N/A | N/A | N/A |
Next qtr. | -8.80% | N/A | N/A | N/A |
Current year | -2.00% | N/A | N/A | N/A |
Next year | 9.40% | N/A | N/A | N/A |
Next 5 years (per annum) | 0.11% | N/A | N/A | N/A |
Past 5 years (per annum) | -0.68% | N/A | N/A | N/A |